Scientific Industries Reports First Quarter Fiscal 2026 Results
Rhea-AI Summary
Scientific Industries (OTCQB: SCND) reported first quarter fiscal 2026 net revenues of $1.23 million, up 30% year over year, driven by Bioprocessing Systems and VIVID pill counter sales. Gross profit rose to $469,900 with gross margin of 38.3%.
Operating expenses decreased 12% to $2.14 million. Net loss narrowed to $1.59 million or $(0.13) per share. Cash, cash equivalents and investments were $5.65 million with working capital of $7.54 million. Expanded VIVID subscriptions launched May 1, 2026.
AI-generated analysis. Not financial advice.
Positive
- Net revenues increased 30% year over year to $1,227,100
- Gross profit grew to $469,900; gross margin improved to 38.3%
- Operating expenses decreased 12% to $2,137,600
- Net loss narrowed to $1,589,300, or $(0.13) per share
- Cash, cash equivalents and investments totaled $5,650,800; working capital $7,543,100
- Expanded VIVID subscription plans launched May 1, 2026 with initial results above expectations
Negative
- Company still reported a net loss of $1,589,300 for the quarter
- Research and development expenses increased 7.9% to $703,700
- No gain from discontinued operations in 2026 versus $278,600 net of tax in prior year
News Market Reaction – SCND
On the day this news was published, SCND gained 1.51%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
REVENUES UP
OPERATING EXPENSES DOWN
SUCCESSFUL LAUNCH OF EXPANDED VIVID SUBSCRIPTION PLANS
BOHEMIA, NY / ACCESS Newswire / May 15, 2026 / Scientific Industries, Inc. (OTCQB:SCND), a developer of digitally simplified bioprocessing solutions, vision-based pill counters and precision scales, today reported financial results for the three months ended March 31, 2026.
Business Highlights
The Company launched its Expanded VIVID subscription plans on May 1st, and initial results exceeded expectations.
Second-generation VIVID ONE is scheduled for launch in summer 2026.
VIVID WORKSTATION AI model development is underway for a planned launch in the first quarter of 2027.
SBI began rolling out pilot pH sensors to select customers.
The Bioprocessing Division ("SBI") is on target with development of an AI tool for bioprocessing applications.
First Quarter Financial Results
Net revenues for the three months ended March 31, 2026 were
Gross profit was
Operating expenses were
The Company recast its financial results for the three months ended March 31, 2025 to reflect the discontinued operations related to the sale of the Genie Division of the Benchtop Laboratory Equipment Operations in August 2025. As a result, it reflected a gain of
The Company reported a net loss for the three months ended March 31, 2026 of
As of March 31, 2026, cash, cash equivalents and investments totaled
Management Commentary
Helena Santos, Chief Executive Officer of Scientific Industries, said, "We began fiscal 2026 with strong momentum across our VIVID and bioprocessing businesses. The launch of our revamped VIVID subscription plans is an important step in building recurring revenue, and development of the second-generation VIVID ONE remains on track for a summer 2026 launch. We were not only encouraged by the increased revenues during the quarter, but also the reduction in total operating expenses despite the increased research and development efforts with total R&D expenses increasing
John Moore, Chairman, said, "In the first quarter of 2026, SBI continued to execute against key priorities - advancing product development, application validation, and software-enabled workflow capabilities. Recently SBI, together with WACKER Biotech US, published a white paper validating the use of SBI's MPS platform in biologics process development workflows. The work demonstrated up to a 2.5x increase in biomass yield through real-time shake flask monitoring and process optimization, highlighting the MPS platform's ability to support greater process insight and more efficient development. SBI also advanced its next-generation pH sensing program, with continued progress in embedded AI development, sensing dye and matrix optimization, and laboratory characterization ahead of initial pilot testing. In parallel, SBI began evaluating production options for pH sensors across multiple form factors, including pills, nanoparticles, microparticles, and coatings. SBI also continued to expand AI-enabled capabilities within its DOTS software platform, including data-driven recommendations, data interpretation support, and predictive growth monitoring. These efforts are designed to strengthen SBI's differentiated position at the intersection of sensor technology, process analytics, and digital bioprocess development."
About Scientific Industries, Inc.
Scientific Industries (OTCQB: SCND), designs, produces, and markets bioprocessing systems under the product name DOTS, and vision-based pill counters under the VIVID® brand in addition to weighing instruments under the brand Torbal®. Scientific Industries' products are generally used in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit www.scientificindustries.com and www.scientificbio.com.
Safe Harbor Statement
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.
Company Contact:
Helena R. Santos
CEO and President
Phone: 631-567-4700
hsantos@scientificindustries.com
info@scientificindustries.com
---FINANCIAL TABLES FOLLOW-
SOURCE: Scientific Industries, Inc.
View the original press release on ACCESS Newswire